'Equipment For Sale': Gaza Journalist Offers To Sell Press Shield To Feed His Starving Family
Gaza-based photojournalist Mohammed Abo Oun offered his camera equipment and press shield to feed his family as the enclave faces an acute hunger crisis due to Israel's offensive.
As the talks for a ceasefire in the ongoing Israel-Hamas war reached another roadblock, a Gaza-based photojournalist's plea to sell his equipment to buy food for his starving family has cast the spotlight on the growing humanitarian crisis and hunger in the besieged Palestinian enclave.
Israel has come under mounting international outrage over severe shortages of food, clean water and medical supplies in wake of its devastating offensive in retaliation for the Hamas-led attacks on October 7, 2023. The humanitarian crisis is now affecting aid workers and journalists as well.
In a LinkedIn post, journalist Mohammed Abo Oun has offered his camera equipment and press shield to buy food for himself and his family. His post has ignited global attention, reflecting a growing desperation among Gaza's population, who are staring at a devastating food scarcity.
'I am the photojournalist Mohammed Abu Aoun from Gaza, I want to offer my equipment and the press shield for sale so that I can buy food for me and my family," he said.
Abo Aoun has contributed to major international media outlets, including The New York Times, Sky News, and ABC News.
Gaza Facing Imminent Famine
The United Nations and NGOs are warning of an imminent famine in the Gaza Strip – a designation based on strict criteria and scientific evidence. 'A large proportion of the population of Gaza is starving", according to the World Health Organisation's chief, Tedros Adhanom Ghebreyesus.
Malnutrition-related deaths have surged this month, with even humanitarian workers struggling to obtain basic food supplies. Israel imposed a total blockade on the entry of aid into Gaza on March 2 after talks to extend a ceasefire broke down. It began to allow a trickle of aid to enter again in late May, but many groups warned that these steps are not enough to prevent the acute scarcity Gaza faces.
Humanitarian organisations have also accused the Israeli army of imposing excessive restrictions on the goods allowed into Gaza and on the routes made available to transport the aid to distribution points.
Israel-Hamas Ceasefire Talks
Furthermore, US President Donald Trump and Israeli Prime Minister Benjamin Netanyahu appeared to abandon Gaza ceasefire negotiations with Hamas on Friday, both saying it had become clear that the Palestinian militants did not want a deal.
'Hamas really didn't want to make a deal. I think they want to die. And it's very bad. And it got to be to a point where you're going to have to finish the job," Trump said, while Netanyahu said Israel was considering 'alternative" options to bring its hostages from Gaza.
'Trump's remarks are particularly surprising, especially as they come at a time when progress had been made on some of the negotiation files," Hamas official Taher al-Nunu told AFP.
(with inputs from agencies)
Get breaking news, in-depth analysis, and expert perspectives on everything from geopolitics to diplomacy and global trends. Stay informed with the latest world news only on News18. Download the News18 App to stay updated!
tags :
gaza crisis Israel Hamas
Location :
Jerusalem, Israel
First Published:
July 26, 2025, 23:08 IST
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
2 hours ago
- Mint
Indian contract drug makers timed their IPOs right. But is the business worth the premium?
An anticipated shift in the global pharmaceutical supply chain away from China has investors excited about Indian contract research, development and manufacturing organisations (CRDMOs), companies that offer services from early-stage drug discovery to late-stage drug development. Export-focused CRDMOs including Anthem Biosciences, Sai Life Sciences and Divi's Laboratories are trading at expensive valuations, reflecting investor enthusiasm as innovator drug companies look at diversifying and derisking their operations. However, experts cautioned that while CRDMOs are expected to post high growth, their financial performances have yet to reflect it. Bengaluru-based Anthem Biosciences made a stellar debut on the stock exchanges on 21 July, listing on the National Stock Exchange at a premium of 27 percent over its initial public offering price of ₹ 570. The IPO, with an issue size of ₹ 3,395.79 crore, was subscribed 67.42 times. Anthem's stock traded at a price-to-earnings (PE) ratio of 93.24 on 25 July. 'The good news is that… China is a behemoth. So, we have that much headroom to grow,' Ajay Bhardwaj, managing director and chief executive officer, told Mint earlier. About 65% of India's imported bulk drugs and advanced drug intermediates worth $3.5 billion in FY25 came from China, according to the commerce ministry. The government wants to strengthen local manufacturing through an upgraded drugs production-linked incentive scheme as it pushes for self-sufficiency in bulk drugs that go into manufacturing medicines. The Indian CRDMO industry today is worth $3-3.5 billion, making up only 2-3% of the global CRDMO market, which is worth $145 billion. It grew at a compound annual growth rate of 15% from 2019-2024, according to a recent report by BCG and IPSO. The industry is at a tipping point, with strong fundamentals and massive headroom to grow, fueled by competitive advantage in small molecule capabilities, faster startup time, focus on quality and cost advantages, the report noted. Unlike CRDMOs, CDMOs (contract development and manufacturing organisations) are typically involved in manufacturing already commercialised drugs. Sai Life Sciences, which made its market debut in December 2024, traded at ₹ 837 on 25 July, close to its high of about ₹ 851, valuing the company at roughly 102 times trailing earnings and about 8.2 times book value. Divi's Laboratories and Syngene International also traded at premiums, at a PE ratio of 80.31 and 55.09, respectively. In comparison, generic pharmaceutical giants are valued relatively modestly: Sun Pharmaceutical Industries trades at a PE ratio of 37.37, Dr Reddy's Laboratories at 18.84, and Cipla at 23.53. Sai Life Sciences shares are up over 18% since listing on the NSE. Divi's Laboratories gained 35.56% from 30 July 2024 to 28 July 2025, Piramal Pharma rose 20.36%, while Syngene International's shares were down 12.72%. Syngene International, a unit of biopharmaceutical company Biocon, kicked off this fiscal's earnings season last week. It posted an 11% year-on-year rise in revenue from operations to ₹ 875 crore for Q1, a robust start compared to its FY25 performance (4% revenue growth YoY). The management maintained its expectation of revenue growth in the mid‑teens for FY26. Sai Life Sciences delivered 16% revenue growth to ₹ 1,695 crore in FY25. Divi's reported a 19% year-on-year rise in full-year revenue to ₹ 9,360 crore in FY25, while net profit surged 37% to ₹ 2,191 crore. Divi's is expected to post revenue growth of 18% year-on-year in Q1FY26, according to brokerage BNP Paribas. 'The Indian CDMO sub-sector presents a highly promising opportunity as investors view it as a direct beneficiary of the China+1 thematic,' Sunil Khaitan, managing director leading financing in India at Goldman Sachs, told Mint. 'We expect the capital markets activity in this space to further accelerate over the next 6-12 months.' The China-plus one theme – to diversify supply chains and reduce overdependence on China – is a key driver, but it's not just that. CRDMOs are on an aggressive capacity expansion track as they anticipate winning over more clients in the future and bank on technological niches to cater to biotech companies as demand for new technologies and drugs grows. Anthem has expertise in new chemical entities as well as biologics (drugs made from living organisms or their components) and capabilities to work on RNAi (a gene regulatory mechanism), antibody drug conjugates that target and kill cancer cells, peptides (short chains of amino acids), lipids, and oligonucleotides (synthesised nucleic acids). OneSource Specialty Pharma, a subsidiary of Strides Pharma, which listed in January, expects its focus on niche areas such as biologics, drug substances, injectables, and drug-device combinations to drive growth. Its offerings in drug-device combinations, particularly for GLP-1s (hormones that regulate blood sugar levels), which are often sold in pen-filled devices, is expected to be a major growth opportunity. 'We are currently executing a 5x expansion of our cartridge-filling capabilities to meet our customer demand and which will significantly boost future revenue,' CEO Neeraj Sharma told Mint in an emailed response. Anthem Biosciences and Sai Life Sciences did not respond to Mint's queries. Investors are looking at CRDMOs not just for potential growth driven by these tailwinds but also as diversification of their portfolios, experts said. Opportunities in traditional pharma companies with a focus on domestic formulations and US generics are drying up because of a slowdown in new approvals and regulatory issues. 'The investor would like to have exposure to companies and segments which have the potential for high growth and themes of shifting manufacturing from China to India,' Tausif Shaikh, healthcare and pharma analyst at BNP Paribas, told Mint. While CRDMOs have reported steady, mid-teen revenue growth, their performance has not been encouraging enough even as valuations remain expensive, Shaikh pointed out. Unlike sectors such as healthcare services, where one can gauge a company's performance based on metrics like hospital bed occupancy and average revenue per bed, for contract drug manufacturers, management commentary is the main indicator of the company's expected growth and performance, said Shaikh. Most companies report an uptick in interest from innovators to hire their services and have embarked on aggressive capacity expansion. Syngene plans to boost its biologics manufacturing footprint in FY26 through its newly acquired US facility for $36.5 million. Divi's Laboratories is undertaking a ₹ 650-700 crore capacity expansion at its existing facilities, while Sai Life Sciences has completed the second phase of its Bidar Unit IV capacity expansion for small-molecule active pharmaceutical ingredients and intermediates. On the back of this, the growth outlook remains strong. "Earnings are expected to be strong for export-oriented CDMOs for the next 2-3 years considering the capex projects and potential addition of new molecules,' Shrikant Akolkar, pharma equity research analyst at brokerage Nuvama, told Mint. However, the CDMO business is non-linear, Akolkar said, adding that one must pay attention to the annual performance and not a couple of quarters of number misses.
The Hindu
2 hours ago
- The Hindu
Israeli strikes kill at least 34 people in Gaza, officials say, as some aid restrictions eased
Israeli strikes killed at least 34 Palestinians in multiple locations across Gaza on Monday (July 28, 2025), local health officials said, a day after Israel eased aid restrictions in the face of a worsening humanitarian crisis in the territory. Israel announced on Sunday (July 27, 2025) that the military would pause operations in Gaza City, Deir al-Balah and Muwasi for 10 hours a day until further notice to allow for the improved flow of aid to Palestinians in Gaza, where concern over hunger has grown, and designate secure routes for aid delivery. Israeli military operations Israel said it would continue military operations alongside the new humanitarian measures. The Israeli military had no immediate comment about the latest strikes, which occurred outside the time frame for the pause Israel declared would be held between 10 a.m. and 8 p.m. Aid agencies have welcomed the new aid measures, which also included allowing airdrops into Gaza, but said they were not enough to counter the rising hunger in the Palestinian territory. Images of emaciated children have sparked outrage around the world, including from Israel's close allies. U.S. President Donald Trump on Sunday called the images of emaciated and malnourished children in Gaza 'terrible.' Israel has restricted aid to varying degrees throughout the war. In March, it cut off the entry of all goods, including fuel, food and medicine to pressure Hamas to free hostages. Israel partially lifted those restrictions in May but also pushed ahead on a new U.S.-backed aid delivery system that has been wracked by chaos and violence. Traditional aid providers also have encountered a similar breakdown in law and order surrounding their aid deliveries. Most of Gaza's population now relies on aid. Accessing food has become a challenge that some Palestinians have risked their lives for. The Awda hospital in central Gaza said it received the bodies of seven Palestinians who it said were killed Monday by Israeli fire close to an aid distribution site run by the U.S.-and Israeli-backed Gaza Humanitarian Foundation. The hospital said 20 others were wounded close to the site. Killings of women and children Elsewhere, a woman who was seven months pregnant was killed along with 11 others after their house was struck in the Muwasi area, west of the southern city of Khan Younis. The woman's fetus survived after a complex surgery, according to the Palestinian Red Crescent. One strike hit a two-story house in the western Japanese neighbourhood of Khan Younis, killing at least 11 people, more than half of them women and children, said the Nasser Hospital, which received the casualties. The Israeli military and GHF did not immediately respond to a request for comment on those strikes. In its October 7, 2023, attack, Hamas killed 1,200 people and took 251 hostages. It still holds 50, more than half Israel believes to be dead. Israel's retaliatory offensive has killed more than 59,800 Palestinians, according to Gaza's Health Ministry. Its count doesn't distinguish between militants and civilians, but the ministry says over half of the dead are women and children. The ministry operates under the Hamas government. The U.N. and other international organisations see it as the most reliable source of data on casualties.
Indian Express
2 hours ago
- Indian Express
Gazans are starving, falling sick, and dying. Why has the UN not declared a ‘famine' in the war-torn land yet?
Populations across Gaza Strip are at the risk of famine, and a third of Gaza's population is going days without eating, according to the UN World Food Programme (WFP). Till Sunday (July 27), aid into the Palestinian enclave was being routed only through the Israeli-American Gaza Humanitarian Foundation (GHF). However, around 900 Gazans in the recent weeks have been killed at the GHF aid sites while trying to gather food, according to the UN human rights office, OHCHR. On Sunday, amid increasing criticism of the humanitarian situation, Israel said it would halt military operations for 10 hours a day in parts of Gaza and allow new aid corridors. However, even as alarm over the crisis in Gaza is rising, officially, famine is yet to be declared in the battered enclave. The Integrated Food Security Phase Classification, or IPC, states that the formal declaration of a famine comes with caution. Set up in 2004, the IPC is the leading international authority on food crises, which includes over a dozen UN agencies, aid groups, governments and other bodies. The IPC was developed during a food emergency in Somalia by the Famine Early Warning Systems Network (FEWS NET) along with global partners. It is coordinated by the UN Food and Agriculture Organisation in Rome. FEWS NET, meanwhile, was established in 1985, in response to famines in East and West Africa when US aid officials realised the need for a way to monitor global hunger. It was founded by the US Agency for International Development (USAID) to collect and analyse data from at-risk areas on a monthly-basis. The IPC defines famine as an extreme deprivation of food, its official website stated. 'Starvation, death, destitution and extremely critical levels of acute malnutrition are or will likely be evident,' as described in the IPC Famine Classification processes. A famine, as per the IPC, can be declared when all of the following three conditions are confirmed: — 20% of households have an extreme lack of food, or are essentially starving. — At least 30% of children (six months to five years old) suffer from acute malnutrition or wasting, meaning they're too thin for their height. — At least two people or four children under five per 10,000 are dying everyday due to starvation or the interaction of malnutrition and disease. Even though the IPC remains the 'primary mechanism' utilised by the international community to determine whether a country is in the grip of a famine, it is often the UN, along with government institutions and multiple other high-level representatives, who possess the authority to declare a famine in an area. Why does the declaration of famine matter? The IPC's classification system acts as a powerful tool in informing, alerting, and mobilising the world before a crisis gets out of hand. Declaring a famine could scale up the global humanitarian response to Gaza. A few countries where the IPC has recently declared famines are Somalia in 2011, South Sudan in 2017 and 2020, and in parts of Sudan's western Darfur region in 2024. What is the status of Gaza? IPC's analyses released on May 12 expected close to 71,000 children under the age of five to be acutely malnourished over the following 11 months (that is, April 2025-March 2026) in these, 14,100 cases were expected to be severe. Moreover, nearly 17,000 pregnant and breastfeeding women would also require treatment for acute malnutrition during this period. IPC categorises hunger crisis on a five-point scale: Phase 1 (Acceptable or, Normal), Phase 2 (Alert or, Stressed), Phase 3 (Serious or, Crisis), Phase 4 (Critical or, Emergency), and Phase 5 (Extremely Critical, Catastrophe or, Famine). Between May to September-end, the IPC projected the whole territory of Gaza to be classified under Emergency (IPC Phase 4), with the entire population expected to face Crisis or worse levels of acute food insecurity (IPC Phase 3 or above). This includes 470,000 people (22 per cent of the population) in Catastrophe (IPC Phase 5), over a million people (54 per cent) in Emergency (IPC Phase 4) and the remaining half million (24 per cent) in Crisis (IPC Phase 3). Also, in Gaza, there persists an impossibility to gather accurate data, with limited access to the territory for experts, and completely damaged infrastructure and care and monitoring networks. The Commissioner-General for the UN Relief and Works Agency for Palestinian Refugees (UNRWA), Philippe Lazzarini, last Thursday posted on X that one in every five children is malnourished in Gaza City. Lazzarini said most UNRWA workers are surviving on a meagre bowl of lentils each day, leading many of them to faint from hunger at work. He also pointed out that UNRWA has 6,000 trucks of food and medical supplies in Jordan and Egypt, which he demanded be immediately let through. 'Families are no longer coping. They are breaking down, unable to survive. Their existence is threatened,' he said. 'Allow humanitarian partners to bring unrestricted and uninterrupted humanitarian assistance to Gaza.' Are there no aid trucks entering Gaza now? The food crisis in Gaza intensified early March this year, when Israel completely cut off all supplies to the 2.3 million residents of the Gaza Strip, demanding Palestinian militant group Hamas to release all the remaining hostages. In May, when the blockade was lifted after 11 weeks, Israel allowed limited UN deliveries to resume, and over 400 Palestinians were killed as they tried to reach the aid sites. Since then, Israel has allowed in around 4,500 trucks from the UN and other aid groups, to distribute, among other things, 2,500 tonnes of baby food and high-calorie special food for children, Israel's Foreign Ministry stated last week. Amid increased international pressure, the Israeli military Saturday night began to airdrop aid into the Strip. These included seven packages of aid containing flour, sugar and canned food, the Israel Defence Forces stated over a Telegram post on Sunday. On Saturday, Israel said that over 250 trucks carrying aid from the UN and other organizations entered Gaza this week. This is much lesser than the about 600 trucks that entered Gaza per day when the ceasefire was in place until March. The Israeli military also said on Saturday that it would establish humanitarian corridors for United Nations convoys, but refrained from providing further details.
